CellaVision evaluates new product for the veterinary market
(Thomson Reuters ONE) - CellaVision, which develops and sells digital morphology products forthe routine analysis of blood and other body fluids, is adapting itscurrent range of products for use in veterinary laboratories. Severalveterinary laboratories are evaluating CellaVision's products inSweden and the US. The results are expected before the end of theyear 2009."The veterinary market is showing interest in our concept and ourproducts for quicker and more standardized analytical results, whichmay open up an entirely new market for our hematology products," saysYvonne Mårtensson, CEO of CellaVision. "A number of Swedishveterinary hospitals have evaluated our product with positiveoutcomes. However, we will wait to decide on when to launch ourproduct until the US market has made an evaluation. We are expectingresults to come in by the end of the year."Veterinary laboratories can use the CellaVision analyzers to assessblood cells as well as create digital images of slide areas,so-called Digital Slides. Blood analysis is an important part ofdiagnosing a number of diseases, including different types ofinfections and blood diseases. The benefits of using CellaVision'sproducts are the same as when using them on human blood, namelyquicker and more standardized results, digital archiving of resultsin patient journals, as well as the transfer of digital images toexperts outside the laboratory.One of the clinical studies was performed at the veterinarylaboratory at the Swedish University of Agricultural Sciences (SLU)in Uppsala. The response was positive:"Being able to make fast and correct diagnoses is of the essence forveterinarians," says Inger Lilliehöök, veterinarian at SLU. "By usingCellaVision's technology, veterinary hospitals can improve thequality of analytical results and increase the ability to diagnose.In that way, pets can be offered the appropriate care."In general, there is potential for medical technology products in theveterinary market. In Sweden there are four regional veterinaryhospitals, 24 medium-sized hospitals, and a number of small animalclinics. One in four Swedish households owns a pet, accounting forthe 1.5 million cats and 950 000 dogs in the country. In the US thereare around 3000 veterinary hospitals with its own laboratory and 50large-sized commercial veterinary laboratories. More than one thirdof the American households own a pet. The number of cats isapproximately 90 million and dogs 73 million.For more information, please contact:Yvonne Mårtensson, CEO, CellaVision ABPhone: +46 46 286 44 01. E-mail: yvonne.martensson(at)cellavision.comAbout CellaVisionCellaVision AB develops, markets, and sells market leading imageanalysis based systems for routine analysis of blood and other bodyfluids. The company has a core competence in development of softwareand hardware for automatic image analysis of cells and cell changesfor applications in health and medical care. The company develops andmarkets systems for automatic differentials of white blood cells andred morphology, and software for education and quality assurance ofdifferentials. The company's associates have expertise in advancedimaging analysis, artificial intelligence, and automated microscopy.The company headquarters are in Lund, Sweden. The company also hassubsidiaries in Florida, USA, Toronto, Canada and Yokohama, Japan.For more information, visit www.cellavision.com.CellaVision's share is listed on First North Premier at the OMXStockholm Stock Exchange. The company's Certified Advisor is RemiumAB.This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 27.08.2009 - 09:03 Uhr
Sprache: Deutsch
News-ID 5164
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 521 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CellaVision evaluates new product for the veterinary market"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
